Medifast Stock Price, News & Analysis (NYSE:MED)

$67.03 2.06 (3.17 %)
(As of 11/18/2017 01:52 AM ET)
Previous Close$67.03
Today's Range$67.40 - $64.86
52-Week Range$38.43 - $71.73
Volume375,604 shs
Average Volume95,007 shs
Market Capitalization$776.16 million
P/E Ratio33.41
Dividend Yield1.91%
Beta0.45

About Medifast (NYSE:MED)

Medifast logoMedifast, Inc. is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins. The Company provides weight loss, weight management and healthy living products and programs through multiple channels of distribution, which include Take Shape For Life; its direct to consumer business unit through its Website and in-house call centers; Franchise Medifast Weight Control Centers, and a national network of physicians. The Company offers a range of weight loss, weight management and healthy products under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape For Life, Flavors of Home and Essential 1 brands. The Company also offers a sports nutrition pilot product line, Dual Fuel.


Industry, Sector and Symbol:
  • Industry: Special Foods & Welbeing Products
  • Sub-Industry: Personal Products
  • Sector: Special Foods & Welbeing Products
  • Symbol: NYSE:MED
  • CUSIP: 58470H10
  • Web: www.medifast1.com
Debt:
  • Current Ratio: 4.39%
  • Quick Ratio: 3.78%
Price-To-Earnings:
  • Trailing P/E Ratio: 33.41
  • Forward P/E Ratio: 30.89
  • P/E Growth: 2.08
Sales & Book Value:
  • Annual Sales: $274.53 million
  • Price / Sales: 2.91
  • Cash Flow: $2.34 per share
  • Price / Cash: 28.70
  • Book Value: $9.07 per share
  • Price / Book: 7.39
Dividend:
  • Annual Dividend: $1.28
  • Dividend Yield: 1.9%
Profitability:
  • Trailing EPS: $2.04
  • Net Income: $17.83 million
  • Net Margins: 8.58%
  • Return on Equity: 24.07%
  • Return on Assets: 19.31%
Misc:
  • Employees: 422
  • Outstanding Shares: 11,930,000
 

Frequently Asked Questions for Medifast (NYSE:MED)

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast declared a quarterly dividend on Thursday, September 7th. Shareholders of record on Friday, September 22nd will be given a dividend of $0.32 per share on Thursday, November 9th. This represents a $1.28 annualized dividend and a yield of 1.91%. The ex-dividend date of this dividend is Thursday, September 21st. View Medifast's Dividend History.

How were Medifast's earnings last quarter?

Medifast Inc (NYSE:MED) released its quarterly earnings results on Tuesday, November, 7th. The specialty retailer reported $0.55 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.51 by $0.04. The specialty retailer had revenue of $77.20 million for the quarter, compared to analysts' expectations of $74.94 million. Medifast had a return on equity of 24.07% and a net margin of 8.58%. The firm's revenue was up 12.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.51 earnings per share. View Medifast's Earnings History.

When will Medifast make its next earnings announcement?

Medifast is scheduled to release their next quarterly earnings announcement on Thursday, March, 8th 2018. View Earnings Estimates for Medifast.

What guidance has Medifast issued on next quarter's earnings?

Medifast updated its fourth quarter earnings guidance on Tuesday, November, 7th. The company provided EPS guidance of $0.46-0.49 for the period, compared to the Thomson Reuters consensus estimate of $0.47. The company issued revenue guidance of $71.4-74.4 million, compared to the consensus revenue estimate of $73.23 million.

Where is Medifast's stock going? Where will Medifast's stock price be in 2017?

2 analysts have issued 1-year target prices for Medifast's shares. Their predictions range from $55.00 to $74.00. On average, they anticipate Medifast's stock price to reach $64.50 in the next twelve months. View Analyst Ratings for Medifast.

Who are some of Medifast's key competitors?

Who are Medifast's key executives?

Medifast's management team includes the folowing people:

  • Michael Charles MacDonald, Executive Chairman of the Board (Age 64)
  • Daniel R. Chard, Chief Executive Officer, Director (Age 52)
  • Timothy G. Robinson CPA, Chief Financial Officer (Age 52)
  • Mehrnaz Mona Ameli, President - OPTAVIA (Age 46)
  • Jason L. Groves Esq., Executive Vice President, General Counsel (Age 46)
  • Jeanne M. City, Executive Vice President - Human Resources (Age 57)
  • Joseph P. Kelleman, Vice President - Finance, Corporate Controller (Age 62)
  • Jeffrey J. Brown, Lead Independent Director (Age 56)
  • Constance J. Hallquist, Director (Age 53)
  • Kevin G. Byrnes, Independent Director (Age 69)

Who owns Medifast stock?

Medifast's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (5.62%), American Century Companies Inc. (2.52%), Bank of New York Mellon Corp (1.66%), Principal Financial Group Inc. (1.39%), JPMorgan Chase & Co. (1.33%) and OxFORD Asset Management LLP (0.72%). Company insiders that own Medifast stock include Balanced Master Fund L Visium, Glenn W Welling, Jeffrey J Brown, Jeremy John Martin, Margaret Sheetz, Ralph Rushton and Simon TP Ridgway. View Institutional Ownership Trends for Medifast.

Who sold Medifast stock? Who is selling Medifast stock?

Medifast's stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, Schroder Investment Management Group, Bank of New York Mellon Corp, Chicago Equity Partners LLC, Systematic Financial Management LP, Virginia Retirement Systems ET AL, Victory Capital Management Inc. and Seizert Capital Partners LLC. Company insiders that have sold Medifast company stock in the last year include Glenn W Welling, Jeremy John Martin and Ralph Rushton. View Insider Buying and Selling for Medifast.

Who bought Medifast stock? Who is buying Medifast stock?

Medifast's stock was purchased by a variety of institutional investors in the last quarter, including American Century Companies Inc., JPMorgan Chase & Co., Principal Financial Group Inc., EAM Investors LLC, Old Mutual Global Investors UK Ltd., OxFORD Asset Management LLP, Aperio Group LLC and Dimensional Fund Advisors LP. Company insiders that have bought Medifast stock in the last two years include Glenn W Welling, Jeffrey J Brown and Simon TP Ridgway. View Insider Buying and Selling for Medifast.

How do I buy Medifast stock?

Shares of Medifast can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medifast's stock price today?

One share of Medifast stock can currently be purchased for approximately $67.03.

How big of a company is Medifast?

Medifast has a market capitalization of $776.16 million and generates $274.53 million in revenue each year. The specialty retailer earns $17.83 million in net income (profit) each year or $2.04 on an earnings per share basis. Medifast employs 422 workers across the globe.

How can I contact Medifast?

Medifast's mailing address is 11445 Cronhill Dr, OWINGS MILLS, MD 21117-2270, United States. The specialty retailer can be reached via phone at +1-732-7640619 or via email at [email protected]


MarketBeat Community Rating for Medifast (NYSE MED)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  137 (Vote Outperform)
Underperform Votes:  163 (Vote Underperform)
Total Votes:  300
MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Medifast (NYSE:MED)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 1 Hold Rating, 1 Buy Rating, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $64.50 (3.77% downside)

Consensus Price Target History for Medifast (NYSE:MED)

Price Target History for Medifast (NYSE:MED)

Analysts' Ratings History for Medifast (NYSE:MED)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/21/2017SidotiReiterated RatingNeutral$49.00 -> $55.00LowView Rating Details
9/15/2017DA DavidsonBoost Price TargetBuy -> Buy$65.00 -> $74.00HighView Rating Details
8/4/2016WunderlichBoost Price TargetHold$32.00 -> $36.00N/AView Rating Details
(Data available from 11/19/2015 forward)

Earnings

Earnings History and Estimates Chart for Medifast (NYSE:MED)

Earnings by Quarter for Medifast (NYSE:MED)

Earnings History by Quarter for Medifast (NYSE MED)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/8/2018        
11/7/2017Q3 2017$0.51$0.55$74.94 million$77.20 millionViewN/AView Earnings Details
8/8/2017Q2 2017$0.53$0.63$71.96 million$75.70 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.49$0.51$72.36 million$70.62 millionViewListenView Earnings Details
3/9/2017Q4 2016$0.33$0.34$65.01 million$62.50 millionViewListenView Earnings Details
11/3/2016Q316$0.45$0.51$66.79 million$68.57 millionViewN/AView Earnings Details
8/3/2016Q216$0.51$0.63$72.01 million$71.14 millionViewN/AView Earnings Details
5/4/2016Q116$0.33$0.42$69.31 million$72.30 millionViewN/AView Earnings Details
3/10/2016Q415$0.35$0.33$62.98 million$61.30 millionViewListenView Earnings Details
11/5/2015Q315$0.42$0.45$67.00 million$65.90 millionViewN/AView Earnings Details
8/5/2015Q215$0.48$0.48$72.79 million$72.20 millionViewN/AView Earnings Details
5/7/2015Q115$0.35$0.46$71.80 million$73.30 millionViewN/AView Earnings Details
3/12/2015Q414$0.46$0.38$69.40 million$62.30 millionViewN/AView Earnings Details
11/5/2014Q314$0.36$0.47$76.10 million$74.00 millionViewN/AView Earnings Details
8/7/2014Q114$0.40$0.44$87.30 million$80.88 millionViewN/AView Earnings Details
5/5/2014Q1$0.37$0.45$87.60 million$86.50 millionViewN/AView Earnings Details
3/10/2014Q413$0.36$0.39$80.83 million$77.30 millionViewN/AView Earnings Details
11/5/2013Q313$0.42$0.41$95.07 million$86.48 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.51$0.51$101.30 million$97.10 millionViewN/AView Earnings Details
5/8/2013Q1 2013$0.34$0.43$93.77 million$96.00 millionViewN/AView Earnings Details
3/7/2013Q4 2012$0.25$0.28$82.90 million$83.20 millionViewN/AView Earnings Details
11/5/2012Q312$0.40$0.42$89.73 million$91.00 millionViewN/AView Earnings Details
7/26/2012$0.38$0.47ViewN/AView Earnings Details
5/8/2012$0.38$0.29ViewN/AView Earnings Details
3/13/2012$0.21$0.08ViewN/AView Earnings Details
11/3/2011$0.38$0.36ViewN/AView Earnings Details
8/4/2011$0.47$0.41ViewN/AView Earnings Details
5/9/2011$0.41$0.44ViewN/AView Earnings Details
3/31/2011$0.32$0.23ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Medifast (NYSE:MED)
2017 EPS Consensus Estimate: $0.99
2018 EPS Consensus Estimate: $2.55
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20171$0.51$0.51$0.51
Q4 20171$0.48$0.48$0.48
Q1 20181$0.60$0.60$0.60
Q2 20181$0.73$0.73$0.73
Q3 20181$0.66$0.66$0.66
Q4 20181$0.56$0.56$0.56
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Medifast (NYSE:MED)

Most Recent Dividend:11/9/2017
Annual Dividend:$1.28
Dividend Yield:1.91%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:62.75% (Trailing 12 Months of Earnings)
58.99% (Based on This Year's Estimates)
50.20% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Medifast (NYSE:MED)

Dividend History by Quarter for Medifast (NYSE MED)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/7/2017quarterly$0.322.31%9/21/20179/22/201711/9/2017
6/7/2017Quarterly$0.323.1%6/21/20176/23/20178/9/2017
3/8/2017quarterly$0.322.92%3/21/20173/23/20175/9/2017
12/9/2016quarterly$0.323.13%12/21/201612/23/20162/9/2017
9/9/2016quarterly$0.252.75%9/21/20169/23/201611/10/2016
6/16/2016quarterly$0.253.04%6/23/20166/27/20168/10/2016
3/10/2016quarterly$0.253.25%3/17/20163/21/20165/10/2016
12/16/2015special$0.2512/23/201512/28/20152/10/2016
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Medifast (NYSE MED)

Insider Ownership Percentage: 6.47%
Institutional Ownership Percentage: 90.67%
Insider Trades by Quarter for Medifast (NYSE:MED)
Institutional Ownership by Quarter for Medifast (NYSE:MED)

Insider Trades by Quarter for Medifast (NYSE MED)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/13/2017Glenn W WellingDirectorSell250,000$65.00$16,250,000.00View SEC Filing  
9/21/2017Ralph RushtonDirectorSell25,000$0.18$4,500.00
9/6/2017Jeremy John MartinDirectorSell131,500$0.18$23,670.00
7/7/2017Simon T.P. RidgwayInsiderBuy1,500$0.15$225.00
7/5/2017Simon T.P. RidgwayInsiderBuy29,000$0.15$4,350.00
3/14/2017Glenn W WellingDirectorBuy17,084$41.33$706,081.72View SEC Filing  
11/15/2016Glenn W WellingDirectorBuy35,000$39.02$1,365,700.00View SEC Filing  
11/9/2016Jeffrey J BrownDirectorBuy10,000$38.71$387,100.00View SEC Filing  
5/31/2016Balanced Master Fund L VisiumMajor ShareholderSell1,350,000$30.25$40,837,500.00View SEC Filing  
4/1/2016Margaret SheetzCOOSell8,333$30.02$250,156.66View SEC Filing  
2/1/2016Margaret SheetzCOOSell8,333$28.62$238,490.46View SEC Filing  
12/1/2015Margaret SheetzCOOSell8,333$29.92$249,323.36View SEC Filing  
11/2/2015Margaret SheetzCOOSell8,333$28.72$239,323.76View SEC Filing  
10/5/2015Margaret SheetzCOOSell8,333$28.88$240,657.04View SEC Filing  
9/4/2015Simon T.P. RidgwayDirectorBuy4,000$0.08$320.00
9/3/2015Margaret SheetzCOOSell6,864$28.00$192,192.00View SEC Filing  
9/2/2015Margaret SheetzCOOSell1,469$28.00$41,132.00View SEC Filing  
9/1/2015Simon T.P. RidgwayDirectorBuy16,000$0.08$1,280.00
8/25/2015Simon T.P. RidgwayDirectorBuy1,000$0.09$85.00
8/24/2015Simon T.P. RidgwayDirectorBuy2,000$0.09$180.00
8/19/2015Simon T.P. RidgwayDirectorBuy15,000$0.10$1,425.00
8/18/2015Simon T.P. RidgwayDirectorBuy35,000$0.10$3,325.00
8/17/2015Radius Gold Inc.InsiderBuy5,000$0.09$450.00
8/14/2015Radius Gold Inc.InsiderBuy35,000$0.10$3,500.00
8/14/2015Simon T.P. RidgwayDirectorBuy10,000$0.10$950.00
6/25/2015Moduslink Global Solutions IncMajor ShareholderSell29,654$33.03$979,471.62View SEC Filing  
6/23/2015Moduslink Global Solutions IncMajor ShareholderSell27,443$33.01$905,893.43View SEC Filing  
6/22/2015Moduslink Global Solutions IncMajor ShareholderSell9,494$33.01$313,396.94View SEC Filing  
6/11/2015Barry B BondroffDirectorSell1,666$31.88$53,112.08View SEC Filing  
6/10/2015Margaret SheetzCOOSell8,337$32.00$266,784.00View SEC Filing  
6/4/2015John P McdanielDirectorSell3,000$32.14$96,420.00View SEC Filing  
8/18/2014Jeannette M MillsEVPSell3,000$28.03$84,090.00View SEC Filing  
6/10/2014Jason L GrovesEVPSell3,250$31.75$103,187.50View SEC Filing  
6/10/2014John P McdanielDirectorSell3,500$31.74$111,090.00View SEC Filing  
6/9/2014Jeannette M MillsEVPSell2,784$32.09$89,338.56View SEC Filing  
6/5/2014Charles P ConnollyDirectorSell7,500$30.91$231,825.00View SEC Filing  
12/2/2013Margaret Macdonald SheetzCOOSell18,000$25.63$461,340.00View SEC Filing  
11/22/2013Margaret Macdonald SheetzCOOSell35,000$24.33$851,550.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Medifast (NYSE MED)

Source:
DateHeadline
MED Dividend Yield Pushes Above 2%MED Dividend Yield Pushes Above 2%
www.thestreet.com - November 17 at 3:57 PM
Medifast Inc (MED) Director Sells $16,250,000.00 in StockMedifast Inc (MED) Director Sells $16,250,000.00 in Stock
www.americanbankingnews.com - November 15 at 7:30 PM
FY2017 EPS Estimates for Medifast Inc (MED) Lifted by DA DavidsonFY2017 EPS Estimates for Medifast Inc (MED) Lifted by DA Davidson
www.americanbankingnews.com - November 9 at 7:34 AM
Noteworthy Wednesday Option Activity: IMPV, MED, CSODNoteworthy Wednesday Option Activity: IMPV, MED, CSOD
www.thestreet.com - November 8 at 5:51 PM
Medifast profit beats estimates as sales rise almost 13 percentMedifast profit beats estimates as sales rise almost 13 percent
www.bizjournals.com - November 8 at 5:51 PM
Edited Transcript of MED earnings conference call or presentation 7-Nov-17 9:30pm GMTEdited Transcript of MED earnings conference call or presentation 7-Nov-17 9:30pm GMT
finance.yahoo.com - November 8 at 5:50 PM
Mid-Day Market Update: CECO Environmental Drops After Q3 Results; Forterra Shares SurgeMid-Day Market Update: CECO Environmental Drops After Q3 Results; Forterra Shares Surge
feeds.benzinga.com - November 8 at 12:44 PM
Medifast Inc (MED) Issues Q4 Earnings GuidanceMedifast Inc (MED) Issues Q4 Earnings Guidance
www.americanbankingnews.com - November 7 at 6:35 PM
MEDIFAST INC (MED) Announces Quarterly  Earnings ResultsMEDIFAST INC (MED) Announces Quarterly Earnings Results
www.americanbankingnews.com - November 7 at 5:27 PM
Medifast Inc (MED) Set to Announce Earnings on TuesdayMedifast Inc (MED) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - October 31 at 1:16 PM
ETFs with exposure to Medifast, Inc. : October 30, 2017ETFs with exposure to Medifast, Inc. : October 30, 2017
finance.yahoo.com - October 31 at 5:16 AM
Medifast, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2017Medifast, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2017
finance.yahoo.com - October 19 at 6:13 AM
Medifast, Inc. : MED-US: Dividend Analysis : September 22nd, 2017 (record date) : By the numbers : October 10, 2017Medifast, Inc. : MED-US: Dividend Analysis : September 22nd, 2017 (record date) : By the numbers : October 10, 2017
finance.yahoo.com - October 11 at 8:26 PM
Medifast, Inc. : MED-US: Dividend Analysis : September 22nd, 2017 (record date) : By the numbers : October 10, 2017Medifast, Inc. : MED-US: Dividend Analysis : September 22nd, 2017 (record date) : By the numbers : October 10, 2017
finance.yahoo.com - October 10 at 8:11 PM
ETFs with exposure to Medifast, Inc. : October 9, 2017ETFs with exposure to Medifast, Inc. : October 9, 2017
finance.yahoo.com - October 9 at 4:03 PM
Medifast®, Together With its Community of OPTAVIA Coaches™, Donate More Than $60,000 to Hurricane Harvey Relief EffortsMedifast®, Together With its Community of OPTAVIA Coaches™, Donate More Than $60,000 to Hurricane Harvey Relief Efforts
finance.yahoo.com - September 26 at 9:13 AM
Sidoti Reiterates Neutral Rating for Medifast Inc (MED)Sidoti Reiterates Neutral Rating for Medifast Inc (MED)
www.americanbankingnews.com - September 21 at 6:58 PM
ETFs with exposure to Medifast, Inc. : September 19, 2017ETFs with exposure to Medifast, Inc. : September 19, 2017
finance.yahoo.com - September 20 at 6:16 AM
Medifast® Announces New Corporate Headquarters in Baltimore CityMedifast® Announces New Corporate Headquarters in Baltimore City
finance.yahoo.com - September 18 at 9:16 PM
Medifast confirms headquarters move to Harbor EastMedifast confirms headquarters move to Harbor East
finance.yahoo.com - September 18 at 9:16 PM
Medifast, Inc. :MED-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017Medifast, Inc. :MED-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 18 at 9:16 PM
DA Davidson Comments on Medifast Incs FY2019 Earnings (MED)DA Davidson Comments on Medifast Inc's FY2019 Earnings (MED)
www.americanbankingnews.com - September 18 at 9:06 AM
Medifast Inc (MED) Price Target Raised to $74.00 at DA DavidsonMedifast Inc (MED) Price Target Raised to $74.00 at DA Davidson
www.americanbankingnews.com - September 15 at 8:00 PM
Medifast Inc Plans Quarterly Dividend of $0.32 (MED)Medifast Inc Plans Quarterly Dividend of $0.32 (MED)
www.americanbankingnews.com - September 7 at 5:28 PM
MEDIFAST INC (MED) Forecasted to Earn Q3 2017 Earnings of $0.51 Per ShareMEDIFAST INC (MED) Forecasted to Earn Q3 2017 Earnings of $0.51 Per Share
www.americanbankingnews.com - August 21 at 2:52 AM
Bloomberg Markets: Dave Wilson’s Stock of the Day for Aug. 17Bloomberg Markets: Dave Wilson’s Stock of the Day for Aug. 17
www.bloomberg.com - August 18 at 6:42 AM
Stock Indexes Retreat Fast; Medifast Thrusts HigherStock Indexes Retreat Fast; Medifast Thrusts Higher
finance.yahoo.com - August 18 at 6:42 AM
Medifast, Inc. – Value Analysis (NYSE:MED) : August 17, 2017Medifast, Inc. – Value Analysis (NYSE:MED) : August 17, 2017
finance.yahoo.com - August 17 at 2:33 AM
Medifast Inc (MED) Now Covered by Analysts at DA DavidsonMedifast Inc (MED) Now Covered by Analysts at DA Davidson
www.americanbankingnews.com - August 16 at 5:40 PM
Medifast stock skyrockets 13 percent to $50 per share after earnings beat Wall Street estimatesMedifast stock skyrockets 13 percent to $50 per share after earnings beat Wall Street estimates
finance.yahoo.com - August 11 at 6:28 AM
Medifast, Inc.: Gathering momentum, can it sustain its performance?Medifast, Inc.: Gathering momentum, can it sustain its performance?
finance.yahoo.com - August 11 at 6:28 AM
Edited Transcript of MED earnings conference call or presentation 8-Aug-17 8:30pm GMTEdited Transcript of MED earnings conference call or presentation 8-Aug-17 8:30pm GMT
finance.yahoo.com - August 10 at 5:02 AM
Medifasts (MED) CEO Daniel Chard on Q2 2017 Results - Earnings Call TranscriptMedifast's (MED) CEO Daniel Chard on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 11:31 PM
Investor Network: Medifast, Inc. to Host Earnings CallInvestor Network: Medifast, Inc. to Host Earnings Call
finance.yahoo.com - August 8 at 11:31 PM
Medifast, Inc. Announces Second Quarter 2017 Financial ResultsMedifast, Inc. Announces Second Quarter 2017 Financial Results
finance.yahoo.com - August 8 at 11:31 PM
Medifast posts 2Q profitMedifast posts 2Q profit
finance.yahoo.com - August 8 at 11:31 PM
MEDIFAST INC (MED) Posts  Earnings Results, Beats Estimates By $0.11 EPSMEDIFAST INC (MED) Posts Earnings Results, Beats Estimates By $0.11 EPS
www.americanbankingnews.com - August 8 at 6:30 PM
MEDIFAST INC (NYSE:MED) Issues Q3 Earnings GuidanceMEDIFAST INC (NYSE:MED) Issues Q3 Earnings Guidance
www.americanbankingnews.com - August 8 at 5:38 PM
MEDIFAST INC (MED) Updates FY17 Earnings GuidanceMEDIFAST INC (MED) Updates FY17 Earnings Guidance
www.americanbankingnews.com - August 8 at 5:38 PM
Medifast, Inc. breached its 50 day moving average in a Bearish Manner : MED-US : August 4, 2017Medifast, Inc. breached its 50 day moving average in a Bearish Manner : MED-US : August 4, 2017
finance.yahoo.com - August 5 at 2:45 AM
MEDIFAST INC (NYSE:MED) to Release Quarterly Earnings on TuesdayMEDIFAST INC (NYSE:MED) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - August 1 at 9:39 AM
Global Weight Loss and Diet Management Market - Industry Forecast to 2025 - Huge Growth Potential from Developing EconomiesGlobal Weight Loss and Diet Management Market - Industry Forecast to 2025 - Huge Growth Potential from Developing Economies
www.finanznachrichten.de - July 25 at 11:55 PM
Take Shape For Life® Rebrands to OPTAVIA™Take Shape For Life® Rebrands to OPTAVIA™
finance.yahoo.com - July 24 at 1:35 PM
When it comes to CEO pay, performance mattersWhen it comes to CEO pay, performance matters
www.bizjournals.com - July 23 at 5:17 AM
MEDIFAST INC (NYSE:MED) vs. Nutraceutical International Corporation (NUTR) Financial ReviewMEDIFAST INC (NYSE:MED) vs. Nutraceutical International Corporation (NUTR) Financial Review
www.americanbankingnews.com - July 20 at 5:21 PM
Medifast, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2017Medifast, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2017
finance.yahoo.com - July 18 at 11:18 PM
MEDIFAST INC (NYSE:MED) & Nutraceutical International Corporation (NUTR) Head to Head AnalysisMEDIFAST INC (NYSE:MED) & Nutraceutical International Corporation (NUTR) Head to Head Analysis
www.americanbankingnews.com - July 17 at 9:54 AM
Head to Head Analysis: Nutraceutical International Corporation (NUTR) vs. MEDIFAST INC (MED)Head to Head Analysis: Nutraceutical International Corporation (NUTR) vs. MEDIFAST INC (MED)
www.americanbankingnews.com - July 14 at 8:50 AM
Financial Analysis: MEDIFAST INC (NYSE:MED) & Nutraceutical International Corporation (NUTR)Financial Analysis: MEDIFAST INC (NYSE:MED) & Nutraceutical International Corporation (NUTR)
www.americanbankingnews.com - July 8 at 8:24 AM
ETFs with exposure to Medifast, Inc. : July 6, 2017ETFs with exposure to Medifast, Inc. : July 6, 2017
finance.yahoo.com - July 7 at 7:22 AM

Social Media

Financials

Chart

Medifast (NYSE MED) Chart for Sunday, November, 19, 2017
Loading chart…

This page was last updated on 11/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.